• Nicotine Signaling in Chronic Kidney Disease

  2026-09-08

  Jain and Jaimes integrate clinical and experimental evidence showing that nicotine may accelerate chronic kidney disease through renal nicotinic acetylcholine receptors, oxidative stress, hemodynamic changes, and profibrotic signaling. The review’s main practical contribution is a mechanistic framework for separating nicotine-specific effects from the broader toxicity of cigarette smoke and for designing more informative kidney injury studies.

• RHEB Neddylation Drives mTORC1 and Liver Tumorigenesis

  2026-09-08

  The reference study identifies RHEB as a non-cullin substrate of the UBE2F-SAG neddylation system and links modification at K169 to lysosomal localization, GTP binding, and mTORC1 activation. Cellular, mouse, and patient-associated evidence supports a role for this pathway in liver steatosis and tumorigenesis while also defining important limits for therapeutic interpretation.

• Berberine–SIRT6–AMPK Signaling in Atrial Fibrillation

  2026-09-07

  This study identifies impaired SIRT6–AMPK signaling as a contributor to angiotensin II-induced atrial remodeling and links that defect to NLRP3 inflammasome activation. Using human atrial samples, bioinformatics, and gain- and loss-of-function experiments in mice, the authors show that berberine reduces oxidative stress, fibrosis, and atrial fibrillation susceptibility through this pathway, while also defining important limits for translation beyond the experimental model.

• NAD+/NADH Homeostasis in Fungal Hypoxia

  2026-09-07

  This award review explains how oxygen limitation reshapes filamentous-fungal metabolism through changes in the NAD+/NADH balance. Its key contribution is linking redox control not only to fermentation, respiration, and growth, but also to secondary-metabolite production through NAD+-dependent regulation of sirtuin A and Nudix hydrolase A.

• Protoporphyrin IX at the Iron–Light Interface

  2026-09-05

  Protoporphyrin IX is a photodynamic compound that connects heme formation, light-driven biology, and iron-dependent cancer research. This article explains how to distinguish photodynamic effects from ferroptosis mechanisms and design more interpretable assays.

• U-73122: Phospholipase C Inhibitor Workflows

  2026-09-04

  U-73122 provides a practical way to interrogate PLC-dependent calcium flux, chemotaxis, inflammation, and cancer-cell invasion. This guide translates its reported activity into controlled assay workflows, quantitative starting conditions, and troubleshooting decisions for reproducible PLC signaling pathway modulation.

• Caspase-8 Fluorometric Assay Kit: Signal to Insight

  2026-09-04

  The Caspase-8 Fluorometric Assay Kit converts IETD-dependent cleavage into a quantitative readout for apoptosis and inflammatory cell-death research. This guide focuses on interpreting caspase-8 activity as causal evidence, using combination-therapy findings to design stronger, orthogonally validated experiments.

• RHEB Neddylation Links UBE2F to Liver Tumorigenesis

  2026-09-03

  The reference study identifies RHEB as a non-cullin substrate of the UBE2F–SAG neddylation axis and shows that modification at K169 strengthens lysosomal localization, GTP binding, and mTORC1 activation. Cellular, genetic mouse, and patient-correlation data connect this mechanism to hepatic steatosis, hepatocellular carcinoma biology, and survival, while also defining important limits for therapeutic translation.

• c-Myc Peptide: From Assay Control to Translation

  2026-09-03

  A strategic guide to using the c-Myc tag Peptide as a sequence-defined displacement reagent, while connecting immunoassay rigor with broader questions about transcription factor stability, signaling, and translational reproducibility.

• Z-VDVAD-FMK in Apoptosis Workflow Design

  2026-09-02

  Z-VDVAD-FMK helps researchers separate caspase-2-centered apoptosis from caspase-independent death and caspase-1-driven pyroptosis. This practical guide covers mitochondrial cytochrome c release inhibition, dose-planning, orthogonal readouts, and troubleshooting for cancer research models.

• Plerixafor (AMD3100) in CXCR4 Research

  2026-09-02

  Plerixafor (AMD3100) provides a reversible way to interrogate CXCL12/CXCR4 signaling in tumor trafficking, stem cell retention, and inflammatory cell movement. This workflow-focused guide connects assay design, dose selection, sample handling, and troubleshooting to practical cancer and hematology research use cases.

• MK-1775: Reading Wee1 Inhibition in Cancer Cells

  2026-09-01

  MK-1775 is a Wee1 kinase inhibitor whose effects are best understood through time-resolved measurements of checkpoint override, proliferation, and cell death. This article translates mechanistic biology and Schwartz’s viability framework into a practical assay strategy for studying DNA damage response inhibition in p53-deficient tumor models.

• Gramine–CUL3–MTDH Ferroptosis in TNBC

  2026-09-01

  The reference study identifies Gramine, also known as 1-(1H-indol-3-yl)-N,N-dimethylmethanamine, as a selective ferroptosis inducer in triple-negative breast cancer through the CUL3–MTDH ubiquitination axis. Its combination of target-engagement assays, ferroptosis rescue experiments, genetic perturbation, and xenograft validation provides a mechanism-focused framework for TNBC and cancer biology research.

• Benzyl Quinolone Carboxylic Acid (BQCA) Workflows

  2026-08-31

  Benzyl Quinolone Carboxylic Acid (BQCA) enables controlled potentiation of M1 signaling instead of relying only on maximal orthosteric stimulation. This practical guide connects BQCA dose–response, BRET-based protein-interaction assays, neuronal activity readouts, and troubleshooting strategies for Alzheimer’s disease research and cognitive function modulation.

• CA800-PR Targets PGR in HR+ Breast Cancer

  2026-08-31

  The reference study introduces CA800-PR, a tumor-targeted heptamethine cyanine dye that combines near-infrared imaging with direct antitumor activity in hormone receptor-positive breast cancer. In MCF-7 models, the dye induced Golgi fragmentation, selectively reduced progesterone receptor protein, promoted apoptosis, and was associated with a pro-inflammatory antitumor immune response.

8045 records 1/537 page Next 12345 下5页 Last page